These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38479588)

  • 21. Application of high-throughput methodologies to the expression of recombinant proteins in E. coli.
    Peleg Y; Unger T
    Methods Mol Biol; 2008; 426():197-208. PubMed ID: 18542865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Non-fused expression of HAb18GEF by reducing stability of translational initiation region in mRNA].
    Zhang SH; Xing JL; Yao XY; Chen ZN
    Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):175-80. PubMed ID: 15969104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small-scale expression of proteins in E. coli.
    Zerbs S; Giuliani S; Collart F
    Methods Enzymol; 2014; 536():117-31. PubMed ID: 24423272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.
    Berlec A; Strukelj B
    J Ind Microbiol Biotechnol; 2013 Apr; 40(3-4):257-74. PubMed ID: 23385853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies for optimization of heterologous protein expression in E. coli: Roadblocks and reinforcements.
    Kaur J; Kumar A; Kaur J
    Int J Biol Macromol; 2018 Jan; 106():803-822. PubMed ID: 28830778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble expression and purification of high-bioactivity recombinant human bone morphogenetic protein-2 by codon optimisation in Escherichia coli.
    Chen W; Zhang C; Wu Y; Su X
    Protein Eng Des Sel; 2019 Dec; 32(3):153-157. PubMed ID: 31603219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretory and extracellular production of recombinant proteins using Escherichia coli.
    Choi JH; Lee SY
    Appl Microbiol Biotechnol; 2004 Jun; 64(5):625-35. PubMed ID: 14966662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for the expression of soluble recombinant protein in Escherichia coli.
    Doyle SA
    Methods Mol Biol; 2005; 310():115-21. PubMed ID: 16350950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced genetic strategies for recombinant protein expression in Escherichia coli.
    Sørensen HP; Mortensen KK
    J Biotechnol; 2005 Jan; 115(2):113-28. PubMed ID: 15607230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli.
    Agrawal A; Bisharyan Y; Papoyan A; Bednenko J; Cardarelli J; Yao M; Clark T; Berkmen M; Ke N; Colussi P
    Protein Expr Purif; 2019 Jan; 153():7-17. PubMed ID: 30081196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges associated with heterologous expression of Flavobacterium psychrophilum proteins in Escherichia coli.
    Shah DH; Cain KD; Wiens GD; Call DR
    Mar Biotechnol (NY); 2008; 10(6):719-30. PubMed ID: 18551344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overcoming the solubility problem in E. coli: available approaches for recombinant protein production.
    Correa A; Oppezzo P
    Methods Mol Biol; 2015; 1258():27-44. PubMed ID: 25447857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretory production of recombinant proteins in Escherichia coli.
    Yoon SH; Kim SK; Kim JF
    Recent Pat Biotechnol; 2010 Jan; 4(1):23-9. PubMed ID: 20201800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene design, fusion technology and TEV cleavage conditions influence the purification of oxidized disulphide-rich venom peptides in Escherichia coli.
    Sequeira AF; Turchetto J; Saez NJ; Peysson F; Ramond L; Duhoo Y; Blémont M; Fernandes VO; Gama LT; Ferreira LM; Guerreiro CI; Gilles N; Darbon H; Fontes CM; Vincentelli R
    Microb Cell Fact; 2017 Jan; 16(1):4. PubMed ID: 28093085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upstream strategies to minimize proteolytic degradation upon recombinant production in Escherichia coli.
    Murby M; Uhlén M; Ståhl S
    Protein Expr Purif; 1996 Mar; 7(2):129-36. PubMed ID: 8812844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient production of soluble recombinant single chain Fv fragments by a Pseudomonas putida strain KT2440 cell factory.
    Dammeyer T; Steinwand M; Krüger SC; Dübel S; Hust M; Timmis KN
    Microb Cell Fact; 2011 Feb; 10():11. PubMed ID: 21338491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput screening for soluble recombinant expressed kinases in Escherichia coli and insect cells.
    Chambers SP; Austen DA; Fulghum JR; Kim WM
    Protein Expr Purif; 2004 Jul; 36(1):40-7. PubMed ID: 15177282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of bioactive chicken follistatin315 in Escherichia coli.
    Lee SB; Choi R; Park SK; Kim YS
    Appl Microbiol Biotechnol; 2014 Dec; 98(24):10041-51. PubMed ID: 25411099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing Recombinant Protein Production in the Escherichia coli Periplasm Alleviates Stress.
    Baumgarten T; Ytterberg AJ; Zubarev RA; de Gier JW
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29654183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical protocols for production of very high yields of recombinant proteins using Escherichia coli.
    Sivashanmugam A; Murray V; Cui C; Zhang Y; Wang J; Li Q
    Protein Sci; 2009 May; 18(5):936-48. PubMed ID: 19384993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.